StemCyte International, Ltd. (TPE:4178)
Taiwan · Delayed Price · Currency is TWD 18.60
-0.30 (-1.59%)
At close: Jun 2, 2026
StemCyte International Revenue
StemCyte International had revenue of 87.81M TWD in the quarter ending March 31, 2026, a decrease of -11.29%. This brings the company's revenue in the last twelve months to 357.74M, down -8.50% year-over-year. In the year 2025, StemCyte International had annual revenue of 368.91M, down -3.60%.
Revenue (ttm)
357.74M
Revenue Growth
-8.50%
P/S Ratio
11.22
Revenue / Employee
n/a
Employees
n/a
Market Cap
4.02B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 368.91M | -13.77M | -3.60% |
| Dec 31, 2024 | 382.69M | 19.91M | 5.49% |
| Dec 31, 2023 | 362.78M | 15.09M | 4.34% |
| Dec 31, 2022 | 347.69M | -509.38M | -59.43% |
| Dec 31, 2013 | 857.07M | 124.33M | 16.97% |
| Dec 31, 2012 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2011 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Globe Union Industrial | 17.67B |
| Chun Yu Works & | 8.03B |
| Mercuries Data Systems | 7.31B |
| Yieh Hsing Enterprise | 4.73B |
| Min Aik Technology | 3.89B |
| Ubiqconn Technology | 1.91B |
| TAIWAN CHELIC | 1.63B |
| Founding Construction Development | 1.16B |